Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis

• Published in: BMC research notes Vol. 2; no. 1; p. 83
• Main Authors: Pemberton, Philip W, Ahmad, Yasmeen, Bodill, Helena, Lokko, Daniel, Hider, Samantha L, Yates, Allen P, Walker, Michael G, Laing, Ian, Bruce, Ian N
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 09.05.2009; BioMed Central; BMC
• Subjects: Antioxidants; Atherosclerosis; Biological markers; Cardiovascular diseases; Demographic aspects; Development and progression; Diagnosis; Health aspects; Oxidative stress; Prevention; Rheumatoid arthritis; Risk factors; Short Report
• ISSN: 1756-0500; 1756-0500
• DOI: 10.1186/1756-0500-2-83

Women with rheumatoid arthritis (RA) have increased morbidity and mortality due to coronary heart disease. Chronic systemic inflammation is known to accelerate atherosclerosis and increase arterial stiffness in patients, but other mechanisms may also be involved. Biomarkers of oxidant stress, inflammation, insulinaemia and endothelial dysfunction were measured in blood and urine from 46 RA patients and 48 age-matched controls. Plaque formation and intima-medial thickness (IMT) were measured using B-mode carotid Doppler scan. The prevalence of plaque was increased (p = 0.042) in RA patients between 50-59 years old compared to the same age group in controls. 8-isoprostane (p = 0.004), C-reactive protein (p < 0.001), interleukin-6 (p < 0.001), insulin (p = 0.035), adiponectin (p = 0.012), vascular cell adhesion molecule (VCAM) (p = 0.029) and E-selectin (p < 0.001) were all increased while selenium (p = 0.003) and LDL-cholesterol (p = 0.025) were both decreased in all RA patients. 8-isoprostane correlated with 10 year cardiac risk (r = 0.55, p < 0.001), VCAM with IMT (r = 0.37, p = 0.012) and E-selectin with rheumatoid factor titre (r = 0.43, p = 0.003) in RA patients. In the control group, age, carotid IMT, VCAM, systolic blood pressure and smoking status were all associated with plaque development whereas in RA patients only age was associated with plaque. The burden of atherosclerosis is particularly increased in middle-aged women with RA. Patients with RA have increased levels of oxidant stress, inflammation, insulin and soluble adhesion molecules. As the association between classical risk factors was much weaker in RA patients compared to controls, these additional factors may be more important in the accelerated development of atheroma in RA.